Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

FD Technologies tender offer taken up in full

(Sharecast News) - FD Technologies announced the results of its tender offer on Friday, after it closed on 22 January, confirming it would purchase the maximum allowable 6,153,846 shares for 1,950p each, returning £120m to shareholders. The AIM-traded firm said that represented 21.8% of the company's issued share capital as of the tender offer record date.

A total of 9,198,383 ordinary shares were validly tendered, equating to 32.6% of the company's issued share capital.

All basic entitlements were accepted in full, while excess tenders were scaled back on a pro-rata basis.

The purchased shares would be cancelled on 29 January.

FD confirmed that no surplus funds remained, and thus, no special dividend would be declared.

Payments to shareholders whose applications were accepted would be dispatched by cheque or CREST payment by the same date.

As part of the tender offer, substantial shareholder Juliana Conlon participated by tendering 1,561,162 ordinary shares, representing 41.05% of her holding.

The company confirmed that her participation, considered a related party transaction under the AIM rules, had been reviewed and deemed fair and reasonable by the board following consultation with its nominated adviser, Investec Bank.

At 0948 GMT, shares in FD Technologies were down 0.21% at 1,946p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

Chesnara's £260m purchase of HSBC Life UK clears regulatory hurdle
(Sharecast News) - Life and pension consolidator Chesnara has received regulatory approval for its £260m acquisition of HSBC's UK life insurance manufacturing business.
GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Orosur nears completion of Pepas drilling
(Sharecast News) - Orosur Mining said drilling at its Pepas gold prospect in Colombia was nearing completion as the company moves toward an initial NI43-101 compliant mineral resource estimate, while first drill holes at its El Pantano project in Argentina have confirmed the presence of a previously undrilled mineral system.
Botswana Diamonds reports progress in 'difficult year' for industry
(Sharecast News) - Botswana Diamonds reported progress across its exploration portfolio for the year ended 30 June despite what it described as a "very difficult year for the diamond industry", as the AIM-listed company diversified into critical minerals and expanded the use of artificial intelligence in its exploration strategy.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.